Fractionated ionizing radiation accelerates loss of amplified MDR1 genes harbored by extrachromosomal DNA in tumor cells

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3845-3854

  Sanchez, Ana M ^a   Barrett, John T ^a   Schoenlein, Patricia V ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CESIUM 137; CIRCULAR DNA; CISPLATIN; COLCHICINE; DOXORUBICIN; EXTRACHROMOSOMAL DNA; VINBLASTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IONIZING RADIATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RADIATION DOSE; TUMOR CELL CULTURE;

DNA, CIRCULAR; DRUG RESISTANCE, MULTIPLE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KB CELLS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEOPLASMS; P-GLYCOPROTEIN;

EID: 0032170889     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Bishop, M. J. Molecular genetics of cancer. Science (Washington DC), 235: 305-311, 1987.
2. Yunis, J. J. The chromosomal basis of human neoplasia. Science (Washington DC), 221: 227-235, 1983.
3. Schimke, R. T. Gene amplification in cultured cells. J. Biol. Chem., 263: 5989-5992, 1988.
4. Tlsty, T. D., Margolin, B. H., and Lum, K. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. USA, 86: 9441-9445, 1989.
5. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington DC), 224: 1121-1124, 1984.
6. Seeger, R. C., Brodeur. G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammon, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
7. Brison, O. Gene amplification and tumour progression. Biochim. Biophys. Acta, 1155: 25-41, 1993.
8. Callender, T., el-Naggar, A. K., Lee, M. S., Frankenthalen, R., Luna, M. A., and Betsakis, J. G. Prad-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous carcinoma. Cancer (Phila.), 74: 152-158, 1994.
9. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Traserra, J., and Cardessa, A. Prod-1/cyclin D-1 gene amplification correlates with messenger RNA overexpression and tumor progression in human Iaryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
10. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
11. Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunnissen, F. B. J. M., Devilie, P., Cornelisse, C. J., van der Vyver, M. J., Mooi, W. J., and Michalides, R. J. A. M. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52: 5229-5234, 1992.
12. Biedler, J. L., and Spengler, B. A. Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science (Washington DC), 191: 185-187, 1976.
13. Biedler, J. L., Melera, P. W., and Spengler, B. A. Specifically altered metaphase chromosomes in antifolate-resistant Chinese hamster cells that overproduce dihydrofolate reductase. Cancer Genet. Cytogenet., 2: 47-60, 1980.
14. Cox, D., Yuncker, C., and Spriggs, A. I. Minute chromatin bodies in malignant tumors of childhood. Lancet, 2: 55-58, 1965.
15. Carroll, S. M., Gaudray, P., DeRose, M. L., Emery, S. F., Meinkoth, J. L., Nakkim, E., Subler, M., Von Hoff, D. D., and Wahl, G. M. Characterization of an episome produced in hamster cells that amplify a transfected CAD gene 31 high frequency: functional evidence for a mammalian replication origin. Mol. Cell. Biol., 7: 1740-1750, 1987.
16. Von Hoff, D. D., Needham-van Devanter, D. R., Yucel, J., Windle, B. E., and Wahl, G. M. Amplified human c-myc oncogenes localized to replicating submicroscopic circular DNA molecules. Proc. Natl. Acad. Sci USA, 85: 4804-4808, 1988.
17. Wahl, G. M. The importance of circular DNA in mammalian gene amplification. Cancer Res., 49: 1333-1340, 1989.
18. Pauletti, G., Lai, E., and Attardi G. Early appearance and long-term persistence of the submicroscopic extrachromosomal elements (amplisomes) containing the amplified DHFR genes in human cell lines. Proc. Natl. Acad. Sci. USA, 87: 2955-2959, 1990.
19. Schoenlein, P. V., Van Devanter, D. R., and Gottesman, M. M. Extrachromosomal elements in mammalian cells. In: E. W. Adolph (ed.), Gene and Chromosome Analysis, Part B, pp. 78-103. San Diego: Academic Press, 1993.
20. Benner, S. E., Wahl, G. M., Von Hoff, D. D. Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anti-Cancer Drugs, 2: 11-25, 1991.
21. McGill, J. R., Beitzel, B. F., Nielsen, J. L., Walsh, J. T., Drabek, S. M., Meador, R. J., and Von Hoff, D. D. Double minutes are frequently found in ovarian carcinomas. Cancer Genet. Cytogenet., 71: 125-131, 1993.
22. Nielsen, J. L., Walsh, J. R., Degen, D. R., Drabek, S. M., McGill, J. R., and Von Hoff, D. D. Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer. Cancer Genet. Cytogenet., 65: 120-124, 1993.
23. Snapka, R. M., and Varshavsky, A. Loss of unstably amplified dihydrofolate reductase genes from mouse cells is greatly accelerated by hydroxyurea. Proc. Natl. Acad. Sci. USA, 80: 7533-7537, 1983.
24. Von Hoff, D. D., Waddelo, T., Forseth, B., Davidson, K., Scott, J., and Wahl, G. M. Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells. Cancer Res., 51: 6273-6279, 1991.
25. Von Hoff, D. D., McGill, J., Davidson, K., Forseth, B., Ebrahim, E. A. A., and Burris, H. Preclinical leads for innovative uses of etoposide. Semin. Oncol., 19: 10-13, 1992.
26. Christen, R. D., Shalinsky, D. R., and Howell, S. B. Enhancement of the loss of multiple drug resistance by hydroxyurea. Semin. Oncol., 19: 94-100, 1992.
27. Von Hoff, D. D., McGill, J. R., Forseth, B. J., Davidson, K. K., Bradley, T. P., VanDevanter, D. R., and Wahl, G. M. Elimination of extrachromosomally amplified c-myc genes from human tumor cells reduces their tumorigenicity. Proc. Natl. Acad. Sci. USA, 89: 8165-8169, 1992.
28. Von Hoff, D. D., McGill, J., Davidson, K., and Wahl, G. Hydroxyurea-induced loss of extrachromosomally amplified oncogenes is mediated through the formation of micronuclei. Proc. Am Assoc. Cancer Res., 33: 359, 1992.
29. Shimizu, N., Nakamura, H., Kadota, T., Kitajima, K., Oda, T., Hirano, T., and Utiyama, H. Loss of amplified c-myc genes in the spontaneously differentiated HL-60 cells. Cancer Res., 54: 3561-3567, 1994.
30. Shen, D. W., Cardarelli, C., Hwang, J., Cornwell, M., Richert, N., Ishii, S., Pastan, I., and Gottesman, M. M. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, Adriamycin, or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 261: 7762-7770, 1986.
31. Shen, D. W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., and Gottesman, M. M. Human multidrug resistant cell lines: increased MDR1 expression can precede gene amplification. Science (Washington DC), 232: 643-645, 1986.
32. Lincke, C. R., Smit, J. J. M., van der Velde-Koerts, T., and Borst, P. Structure of the human MDR3 gene and physical mapping of the human MDR locus. J. Biol. Chem., 266: 5303-5310, 1991.
33. Schoenlein, P. V., Shen, D., Barrett, J. T., Pastan, I., and Gottesman, M. M. Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells. Mol. Biol. Cell, 3: 507-520, 1992.
34. Schoenlein, P. V. Molecular cytogenetics of multiple drug resistance. Cytotechnology, 12: 63-89, 1993.
35. Sambrook, S., Frisch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Plainview, NY: Cold Spring Harbor Laboratory, 1989.
36. Chin, K., Tanaka, S., Darlington, G., Pastan, I., and Gottesman, M. M. Heat shock and arsenite increase expression of the multidrug resistance (MDRI) gene in human renal carcinoma cells. J, Biol. Chem., 265: 221-226, 1990.
37. Tso, J. Y., Sun, X., Kao, T., Reese, K. S., and Wu, R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase c-DNA: genomic complexity and molecular evolution of the gene. Nucl. Acids Res., 13: 2485-2502, 1985.
38. Akiyama, S. I., Fojo, A., Hanover, J. A., Pastan, I., and Gottesman, M. M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol. Genet., 11: 117-126, 1985.
39. Germann, U. A., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance-adenosine deaminase fusion gene. J. Biol. Chem., 264: 7418-7424, 1989.
40. Kartner, N., Evernden-Porelle, D., Bradley, G., and Ling, V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (Lond.), 316: 820-823, 1985.
41. Kokuhu, N., Cohen, D., and Watanabe, T. Functional modulation of ATPase of P-glycoprotein by C219, a monoclonal antibody against P-glycoprotein. Biochem. Biophys. Res. Commun., 230: 398-401, 1997.
42. Countryman, P. L. and Heddle, J. A. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat. Res., 41: 321-332, 1976.
43. Nusse, M., Beisker, W., Kramer, J., Miller, B. M., Schreiber, G. A., Viaggi, S., Weller, E. M., and Wessels, J. M. Measurement of micronuclei by flow cytometry. Methods Cell. Biol., 42: 149-158, 1994.
44. Fojo, A. T., Whang-Peng, J., Gottesman, M. M., and Pastan, I. Amplification of DNA sequences in human MDR KB carcinoma cells. Proc. Natl. Acad. Sci. USA, 82: 7661-7665, 1985.
45. Ruiz, J. C., Choi, K., Von Hoff, D. D., Roninson I. B., and Wahl, G. M. Autonomously replicating episomes contain mdr1 genes in a multidrug-resistant human cell line. Mol. Cell. Biol., 9: 109-115, 1989.
46. Ueda, K., Cardarelli, C., Gottesman, M. M., and Pastan, I. Expression of a full-length cDNA for the human "MOR 1" (P-glycoprotein) gene confers multidrug resistance to colchicine: doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84: 3004-3008, 1987.
47. Gottesman, M. M., and Pastan, I. The multidrug transporter-a double-edged sword. J. Biol. Chem., 263: 12163-12166, 1988.
48. Endicott, J. A., and Ling, V. The biochemistry of P-glycoprotein-mediated MDR. Annu. Rev. Biochem., 58: 137-171, 1989.
49. Shimizu, N., Kanda, T., and Wahl, G. M. Selective capture of acentric fragments by micronuclei provides a rapid method for purifying extrachromosomally amplified DNA. Nat. Genet., 12: 65-71, 1996.
50. Lambda, J. R., Petit-Frere, C., Broughton, B. C., Lehmann, A. R., and Green, M. H. L. Inhibition of DNA replication by ionizing radiation is mediated by a trans-acting factor. Int. J. Radiat. Biol., 56: 125-130, 1989.
51. Cleaver, J. E., Rose, R., and Mitchell, D. L. Replication of chromosomal and episomal DNA in X-ray-damaged human cells: a cis-or trans-acting mechanism. Radiat. Res., 124: 294-299, 1990.
52. Hall, E. J. Time, dose, and fractionation in radiotherapy. In: E. J. Hall (ed.), Radiology for the Radiologist, pp. 211-229. Philadelphia: J. B. Lippincott Co., 1994.
53. Uckun, F. M., Mitchell, J. B., Obuz, V., Chandan-Langlie, M., Min, W. S., Haissig, S., and Song, C. W. Radiation and heat sensitivity of human T-lineage acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML) clones displaying multiple drug resistance (MDR). Int. J. Radiat. Oncol., 23: 115-125, 1992.
54. Schimke, R. T., Brown, P. C., Kaufman, R. J., McGrogan, M., and Slate, D. L. Chromosomal and extrachromosomal localization of amplified dihydrofolate reductase genes in cultured mammalian cells. Cold Spring Harbor Symp. Quant. Biol., 45: 785-798, 1981.
55. Kaufman, R. J., and Schimke, R. T. Amplification and loss of dihydrofolate reductase genes in a Chinese hamster ovary cell line. Mol. Cell. Biol., 1: 1069-1076, 1981.
56. Masters, J., Keeley, B., Gay, H., and Attardi, G. Variable content of double minute chromosomes is not correlated with degree of phenotype instability in methotrexate-resistant human cell lines. Mol. Cell. Biol., 2: 498-507, 1982.
57. Varshavsky, A. Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion. Cell, 25: 561-572, 1981.
58. Barker, PE. Double minutes in human tumor cells. Cancer Genet. Cytogenet., 5: 81-94, 1982.
59. Cowell, J. K. Double minutes and homogeneously staining regions: gene amplification in mammalian cells. Annu. Rev. Genet., 16: 21-59, 1982.
60. Levan, A., and Levan, G. Have double minutes functioning centromeres'? Heriditas, 88: 81-92, 1978.
61. Midander, J., and Revesz, L., The frequency of micronuclei as a measure of cell survival in irradiated cell populations. Int. J. Radiat. Biol., 38: 237-242, 1980.
62. Muller, W-U., Nusse, M., Miller, B. M., Slavotinek, A., Viaggi, S., and Streffer, C. Micronuclei: a biological indicator of radiation damage. Mutat. Res., 366: 163-169, 1996.
63. Mitchell, J. C., and Norman, A. The induction of micronuclei in human lymphocytes by low doses of radiation. Int. J. Radiat. Biol., 52: 527-535, 1987.
64. Yu, D., Liu, B., Tan, M., Li, J., Wang, S-S., and Hung, M-C. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene, 13: 1359-1365, 1996.
65. Eliot, H. E., Borner, M. M., Sinha, B. K. differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance. Anticancer Res., 15: 729-733, 1995.
66. Tsai, C-M., Chang, K-T., Perng, R-P., Mitsudomi, T., Chen, M-H., Kadoyama, C., and Gazdar, A. F. Enhanced chemoresistance by elevation of p185 neu levels in HER-2/neu-transfected human lung cancer cells. J. Natl. Cancer Inst., 85: 897-901, 1993.
67. Stuhlinger, M., Helmer, H., Dobianer, K., Hruza, C., Rainer, H., Locker, G., and Spona, J. Clinical therapy and HER-2 oncogene amplification in breast cancer: chemo-versus radiotherapy. J. Steroid Biochem. Mol. Biol., 49: 39-42, 1994.
68. Carver, J. H., Dewey, W. C., and Hopwood, L. E. X-ray-induced mutants resistant to 8-azaguanine. I. Effects of cell density and expression time. Mutat. Res., 34: 447-464, 1976.
69. Nakamura, N., Suzuki, S., Ito, A., and Okada, S. Mutations induced by γ-rays and fast neutrons in cultured mammalian cells. Differences in dose response and RBE with methotrexate-and 6-thioguanine-resistant systems. Mutat. Res., 104: 383-387, 1982.
70. Osmak, M., and Perovic, S. Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum(II) and methotrexate in human HeLa cells. Int. J. Radiat. Oncol. Biol. Phys., 16: 1537-1541, 1989.
71. Thacker, J., Stretch, A., and Stephens, M. A. The induction of thioguanine-resistant mutants of Chinese hamster cells by γ-rays. Mutat. Res., 42: 313-326, 1977.
72. Hopwood, L. E., Davies, B. M., Moulder, B. S., and Moulder, J. E. Drug resistance following irradiation of RIF-1 tumors: influence of the interval between irradiation and drug treatment. Int. J. Radiat. Oncol. Biol. Phys., 19: 643-650, 1990.
73. Hill, B. T., Deuchars, K., Hosking, L. K., Ling, V., and Whelan, R. D. H. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro. J. Natl. Cancer Inst., 82: 607-611, 1990.
74. Hill, B. T., Whelan, R. D., Hurst, H. C., and McClean, S. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation. Cancer (Phila.), 73: 2990-2999, 1995.
75. McClean, S., Whelan, R. D. H., Hosking, L. K., Hodges, G. M., Thompson, F. H., Meyers, M. B., Schuurhuis, G. J., and Hill, B. T. Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in vitro exposure to fractionated X-irradiation. Biochim. Biophys. Acta, 1177: 117-126, 1993.
76. Mattern, J., Efferth, T., and Volm, M. Overexpression of P-glycoprotein in human lung carcinoma xenografts after fractionated irradiation in vivo. Radiat. Res., 127: 335-338, 1991.
77. Goldstein, L. J., Galski, H., Fojo, A. T., Willingham, M. C., Lai, S-L., Gazdar, A., Pirker, R., Green, A., Crist, J. W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.